Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for COVID-19 Smell Loss
NCT05461365Phase 3Completed
- Sponsor
- Universidad Panamericana
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Generex Oral-lyn in anosmia, Hyposmia, sponsored by Universidad Panamericana. Started Jan 2021; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
anosmiaHyposmia
Beyond the preview
Go deeper on NCT05461365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461365.